Fast screening and structural elucidation of G-quadruplex ligands from a mixture via G-quadruplex recognition and NMR methods.
暂无分享,去创建一个
Lin Li | Yalin Tang | Junfeng Xiang | Qiuju Zhou | Yalin Tang | J. Xiang | Hongxia Sun | Hongxia Sun | Qiuju Zhou | Lin Li
[1] Yalin Tang,et al. Regulation and recognization of the extended G-quadruplex by rutin. , 2007, Biochemical and biophysical research communications.
[2] Craig M. Crews,et al. Molecular Understanding and Modern Application of Traditional Medicines: Triumphs and Trials , 2007, Cell.
[3] S. Balasubramanian,et al. Targeting nucleic acid secondary structures with polyamides using an optimized dynamic combinatorial approach. , 2005, Angewandte Chemie.
[4] Jean-Louis Mergny,et al. G-quadruplex DNA: A target for drug design , 1998, Nature Medicine.
[5] T. Tsuruo,et al. FJ5002: a potent telomerase inhibitor identified by exploiting the disease-oriented screening program with COMPARE analysis. , 1999, Cancer research.
[6] S. Balasubramanian,et al. Trisubstituted isoalloxazines as a new class of G-quadruplex binding ligands: small molecule regulation of c-kit oncogene expression. , 2007, Journal of the American Chemical Society.
[7] D. Patel,et al. Solution structure of a parallel-stranded G-quadruplex DNA. , 1993, Journal of molecular biology.
[8] K. Shin‐ya,et al. Telomerase inhibition with a novel G-quadruplex-interactive agent, telomestatin: in vitro and in vivo studies in acute leukemia , 2006, Oncogene.
[9] Jean-Louis Mergny,et al. Detection of telomerase inhibitors based on g-quadruplex ligands by a modified telomeric repeat amplification protocol assay. , 2002, Cancer research.
[10] D. Newman,et al. Natural products as sources of new drugs over the last 25 years. , 2007, Journal of natural products.
[11] J. Mergny,et al. The development of telomerase inhibitors: the G-quartet approach. , 1999, Anti-cancer drug design.
[12] Mengfen Lin,et al. Diffusion-Edited NMR−Affinity NMR for Direct Observation of Molecular Interactions , 1997 .
[13] J. Mergny,et al. Ethidium derivatives bind to G-quartets, inhibit telomerase and act as fluorescent probes for quadruplexes. , 2001, Nucleic acids research.
[14] M. Searle,et al. Drug recognition and stabilisation of the parallel-stranded DNA quadruplex d(TTAGGGT)4 containing the human telomeric repeat. , 2003, Journal of Molecular Biology.
[15] D. Bearss,et al. Direct evidence for a G-quadruplex in a promoter region and its targeting with a small molecule to repress c-MYC transcription , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[16] P. Pečinka,et al. DNA tetraplex formation in the control region of c-myc. , 1998, Nucleic acids research.
[17] M F Balandrin,et al. Natural plant chemicals: sources of industrial and medicinal materials. , 1985, Science.
[18] David M. Prescott,et al. Inhibition of telomerase by G-quartet DMA structures , 1991, Nature.
[19] M. Searle,et al. Recognition and stabilization of quadruplex DNA by a potent new telomerase inhibitor: NMR studies of the 2:1 complex of a pentacyclic methylacridinium cation with d(TTAGGGT)4 , 2001 .
[20] E. De Pauw,et al. Selective interaction of ethidium derivatives with quadruplexes: an equilibrium dialysis and electrospray ionization mass spectrometry analysis. , 2003, Biochemistry.
[21] Laurence H. Hurley,et al. DNA and its associated processes as targets for cancer therapy , 2002, Nature Reviews Cancer.
[22] G. Morris,et al. A novel NMR method for screening soluble compound libraries , 2001 .
[23] Dinshaw J. Patel,et al. Human telomere, oncogenic promoter and 5′-UTR G-quadruplexes: diverse higher order DNA and RNA targets for cancer therapeutics , 2007, Nucleic acids research.
[24] M. Shapiro,et al. Screening Mixtures by Affinity NMR , 1997 .
[25] S. Neidle,et al. Natural and synthetic G-quadruplex interactive berberine derivatives. , 2006, Bioorganic & medicinal chemistry letters.